What's new

Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 18, Status: Authorised

Feb 27, 2025 - 10:29
 0
Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, D...

Next Article

The Value of Device Characterization for the Optimization of Organic Solar Cells

Related Posts

Human medicines European public assessment report (EPAR): Respreeza, alpha1-proteinase inhibitor (human), Date of authorisation: 20/08/2015, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0

Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation: 14/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 7, 2025  0

Dynastat

Dynastat

Apr 14, 2025  0